|
ATE472338T1
(de)
|
2003-02-20 |
2010-07-15 |
Seattle Genetics Inc |
Anti-cd70 antikörper-arzneimittelkonjugate und ihre verwendung zur behandlung von krebs
|
|
US8455622B2
(en)
|
2006-12-01 |
2013-06-04 |
Seattle Genetics, Inc. |
Variant target binding agents and uses thereof
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
IL271761B
(en)
|
2009-02-05 |
2022-09-01 |
Immunogen Inc |
(12as)-8-methoxy-9-benzyloxy-11,12,12a,13-tetrahydro-6h-indolo[2,1-c][1,4]benzodiazepin-6-one, 4-benzyloxy-5-methoxy-2-nitrobenzoic acid and processes for preparing the same
|
|
MX2012011900A
(es)
|
2010-04-15 |
2013-03-21 |
Seattle Genetics Inc |
Conjugados de pirrolobenzodiazepina diana.
|
|
EP2558475A1
(en)
|
2010-04-15 |
2013-02-20 |
Spirogen Sàrl |
Pyrrolobenzodiazepines used to treat proliferative diseases
|
|
CN113896731A
(zh)
|
2011-02-15 |
2022-01-07 |
伊缪诺金公司 |
细胞毒性苯并二氮杂䓬衍生物
|
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
|
KR101860174B1
(ko)
|
2011-09-20 |
2018-05-21 |
메디뮨 리미티드 |
표적 접합체 내의 내포를 위한 비대칭 이량체 pbd 화합물로서 피롤로벤조디아제핀
|
|
CN103998449A
(zh)
|
2011-10-14 |
2014-08-20 |
斯皮罗根有限公司 |
吡咯并苯并二氮杂卓
|
|
BR112014008888A2
(pt)
|
2011-10-14 |
2017-04-18 |
Seattle Genetics Inc |
pirrolobenzodiazepinas
|
|
CN103987384A
(zh)
|
2011-10-14 |
2014-08-13 |
西雅图基因公司 |
吡咯并苯并二氮杂卓和靶向结合物
|
|
CN103997893B
(zh)
|
2011-10-14 |
2019-04-12 |
西雅图基因公司 |
吡咯并苯并二氮杂卓和靶向结合物
|
|
SI2817338T1
(sl)
|
2012-02-24 |
2017-11-30 |
Abbvie Stemcentrx Llc |
Modulatorji DLL3 in postopki uporabe
|
|
KR102099073B1
(ko)
|
2012-02-24 |
2020-04-10 |
애브비 스템센트알엑스 엘엘씨 |
항 ｓｅｚ6 항체들 및 사용 방법
|
|
US20130309223A1
(en)
*
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
HRP20181646T2
(hr)
*
|
2012-10-12 |
2019-08-09 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin - anti-psma protutijela
|
|
JP6367204B2
(ja)
|
2012-10-12 |
2018-08-01 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
結合用のピロロベンゾジアゼピン誘導体の合成および中間体
|
|
JP2016502504A
(ja)
*
|
2012-10-12 |
2016-01-28 |
エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ |
ピロロベンゾジアゼピン−抗体結合体
|
|
HRP20171916T1
(hr)
*
|
2012-10-12 |
2018-02-09 |
Adc Therapeutics Sa |
Konjugati protutijelo anti-cd22 - pirolobenzodiazepin
|
|
US10736903B2
(en)
|
2012-10-12 |
2020-08-11 |
Medimmune Limited |
Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
|
|
US9931415B2
(en)
|
2012-10-12 |
2018-04-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CA2885340C
(en)
|
2012-10-12 |
2016-11-08 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
PT3470086T
(pt)
*
|
2012-10-12 |
2021-02-01 |
Medimmune Ltd |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
WO2014057118A1
(en)
*
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
SMT201900017T1
(it)
|
2012-10-12 |
2019-02-28 |
Medimmune Ltd |
Coniugati pirrolobenzodiazepina-anticorpo
|
|
AU2013340449B2
(en)
*
|
2012-11-05 |
2017-11-30 |
Pfizer Inc. |
Spliceostatin analogs
|
|
US9353150B2
(en)
|
2012-12-04 |
2016-05-31 |
Massachusetts Institute Of Technology |
Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
|
|
AU2013366490B9
(en)
*
|
2012-12-21 |
2018-02-01 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
BR112015014669B1
(pt)
|
2012-12-21 |
2023-09-26 |
Medimmune Limited |
Compostos pirrolobenzodiazepinas, conjugados compreendendo os mesmos e uso destes para tratar uma doença proliferativa
|
|
KR20160037130A
(ko)
*
|
2013-02-22 |
2016-04-05 |
스템센트알엑스 인코포레이티드 |
신규한 항체 접합체 및 이의 용도
|
|
EA027910B1
(ru)
|
2013-03-13 |
2017-09-29 |
Медимьюн Лимитед |
Пирролобензодиазепины и их конъюгаты
|
|
ES2702181T3
(es)
|
2013-03-13 |
2019-02-27 |
Seattle Genetics Inc |
Filtración con carbono activado para la purificación de ADC de benzodiazepina
|
|
NZ712035A
(en)
|
2013-03-13 |
2019-06-28 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN105142674B
(zh)
|
2013-03-13 |
2018-11-13 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
KR102274714B1
(ko)
*
|
2013-03-13 |
2021-07-09 |
씨젠 인크. |
사이클로덱스트린 및 항체-약물 포합체 제형
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
CA2918139A1
(en)
*
|
2013-08-12 |
2015-02-19 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
JP2016531915A
(ja)
|
2013-08-28 |
2016-10-13 |
ステムセントリックス， インコーポレイテッド |
部位特異的抗体コンジュゲーション方法および組成物
|
|
JP2016531914A
(ja)
*
|
2013-08-28 |
2016-10-13 |
ステムセントリックス， インコーポレイテッド |
操作された抗ｄｌｌ３コンジュゲートおよび使用方法
|
|
CA2922529A1
(en)
|
2013-08-28 |
2015-03-05 |
Stemcentrx, Inc. |
Novel sez6 modulators and methods of use
|
|
JP6332773B2
(ja)
|
2013-09-02 |
2018-05-30 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
薬物と細胞結合分子との共役のための新規細胞毒性分子
|
|
KR20160055253A
(ko)
|
2013-09-12 |
2016-05-17 |
할로자임, 아이엔씨 |
변형된 항-상피세포 성장인자 수용체 항체 및 이의 사용 방법
|
|
EP3054985B1
(en)
|
2013-10-11 |
2018-12-26 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3054986B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3054983B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
KR102356814B1
(ko)
|
2013-10-15 |
2022-01-28 |
씨젠 인크. |
개선된 리간드-약물 컨쥬게이트 약물동력학을 위한 peg화된 약물-링커
|
|
MX2016005763A
(es)
|
2013-11-06 |
2016-08-19 |
Stemcentrx Inc |
Anticuerpos anti-claudina novedosos y metodos de uso.
|
|
US10457976B2
(en)
|
2013-11-25 |
2019-10-29 |
Seattle Genetics, Inc. |
Preparing antibodies from CHO cell cultures for conjugation
|
|
AU2014361856A1
(en)
|
2013-12-12 |
2016-06-30 |
Abbvie Stemcentrx Llc |
Novel anti-DPEP3 antibodies and methods of use
|
|
EP3082876B1
(en)
|
2013-12-16 |
2018-01-17 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
TWI727919B
(zh)
|
2013-12-19 |
2021-05-21 |
美商西雅圖遺傳學公司 |
與標的-藥物結合物併用之亞甲基胺基甲酸酯連接物
|
|
WO2015127407A1
(en)
|
2014-02-21 |
2015-08-27 |
Stemcentrx, Inc. |
Anti-dll3 antibodies and drug conjugates for use in melanoma
|
|
SG11201607818WA
(en)
|
2014-03-20 |
2016-10-28 |
Bristol Myers Squibb Co |
Stabilized fibronectin based scaffold molecules
|
|
CA2942101A1
(en)
|
2014-03-21 |
2015-09-24 |
Abbvie Inc. |
Anti-egfr antibodies and antibody drug conjugates
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
TW201617368A
(zh)
*
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗ｍｆｉ２抗體及使用方法
|
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
ES2830385T3
(es)
|
2014-09-12 |
2021-06-03 |
Genentech Inc |
Anticuerpos e inmunoconjugados anti-HER2
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
SMT202000413T1
(it)
|
2014-11-21 |
2020-09-10 |
Bristol Myers Squibb Co |
Anticorpi nei confronti di cd73 e loro usi
|
|
MX386942B
(es)
|
2014-11-21 |
2025-03-19 |
Bristol Myers Squibb Co |
Anticuerpos que comprenden regiones constantes pesadas modificadas.
|
|
CA2968447A1
(en)
|
2014-11-25 |
2016-06-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms
|
|
AU2015353573B2
(en)
|
2014-11-25 |
2020-09-03 |
Bristol-Myers Squibb Company |
Novel PD-L1 binding polypeptides for imaging
|
|
ES2783624T3
(es)
|
2015-01-14 |
2020-09-17 |
Bristol Myers Squibb Co |
Dímeros de benzodiacepina, conjugados de los mismos y métodos de preparación y uso
|
|
JP6676058B2
(ja)
|
2015-01-14 |
2020-04-08 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ヘテロアリーレン架橋したベンゾジアゼピン二量体、そのコンジュゲート、ならびに製造および使用方法
|
|
EP3268048B1
(en)
|
2015-03-10 |
2019-05-08 |
Bristol-Myers Squibb Company |
Antibodies conjugatable by transglutaminase and conjugates made therefrom
|
|
AU2016246134B2
(en)
|
2015-04-10 |
2022-04-21 |
Thomas Jefferson University |
Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytes
|
|
GB201506389D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
PT3303396T
(pt)
|
2015-05-29 |
2023-01-30 |
Bristol Myers Squibb Co |
Anticorpos contra ox40 e utilizações dos mesmos
|
|
TW201709932A
(zh)
|
2015-06-12 |
2017-03-16 |
西雅圖遺傳學公司 |
Ｃｄ１２３抗體及其共軛物
|
|
MX2017015814A
(es)
|
2015-06-23 |
2018-04-10 |
Squibb Bristol Myers Co |
Dimeros de benzodiazepina macrociclica, conjugados de los mismos, preparacion y usos.
|
|
PT3316909T
(pt)
|
2015-06-30 |
2023-11-22 |
Seattle Genetics Inc |
Anticorpos anti-ntb-a e composições e métodos relacionados
|
|
IL294651B2
(en)
*
|
2015-07-21 |
2024-02-01 |
Immunogen Inc |
Methods for the preparation of cytotoxic benzodiazepine compounds
|
|
JP6951340B2
(ja)
|
2015-09-23 |
2021-10-20 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
グリピカン−３結合フィブロネクチンベース足場分子
|
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
|
US11413353B2
(en)
*
|
2015-11-25 |
2022-08-16 |
Legochem Biosciences, Inc. |
Conjugates comprising self-immolative groups and methods related thereto
|
|
AU2016365117A1
(en)
|
2015-11-30 |
2018-05-31 |
Abbvie Biotherapeutics Inc. |
Anti-huLRRC15 antibody drug conjugates and methods for their use
|
|
US10188660B2
(en)
|
2015-11-30 |
2019-01-29 |
Abbvie Inc. |
Anti-huLRRC15 antibody drug conjugates and methods for their use
|
|
WO2017096311A1
(en)
|
2015-12-04 |
2017-06-08 |
Seattle Genetics, Inc. |
Conjugates of quaternized tubulysin compounds
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
AU2016364853A1
(en)
*
|
2015-12-04 |
2018-06-21 |
Abbvie Stemcentrx Llc |
Novel anti-claudin antibodies and methods of use
|
|
GB201521709D0
(en)
*
|
2015-12-09 |
2016-01-20 |
Kings College London And Sec Dep For Health The |
PBD Antibacterial agents
|
|
AU2016377371A1
(en)
|
2015-12-21 |
2018-08-09 |
Bristol-Myers Squibb Company |
Variant antibodies for site-specific conjugation
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
KR20230038311A
(ko)
|
2016-03-04 |
2023-03-17 |
브리스톨-마이어스 스큅 컴퍼니 |
항-cd73 항체와의 조합 요법
|
|
EP3442584B1
(en)
|
2016-03-15 |
2021-07-28 |
Seagen Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
WO2017161206A1
(en)
|
2016-03-16 |
2017-09-21 |
Halozyme, Inc. |
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
|
|
SG11201807827VA
(en)
|
2016-03-25 |
2018-10-30 |
Seattle Genetics Inc |
Process for the preparation of pegylated drug-linkers and intermediates thereof
|
|
MA45328A
(fr)
|
2016-04-01 |
2019-02-06 |
Avidity Biosciences Llc |
Compositions acide nucléique-polypeptide et utilisations de celles-ci
|
|
EP3442591A4
(en)
*
|
2016-04-15 |
2019-11-20 |
Seattle Genetics, Inc. |
COMBINATIONS OF CD33 ANTIBODY-ACTIVE CONJUGATES WITH HYPOMETHYLATING AGENTS
|
|
CA3021098A1
(en)
|
2016-04-21 |
2017-10-26 |
Abbvie Stemcentrx Llc |
Novel anti-bmpr1b antibodies and methods of use
|
|
GB201607478D0
(en)
*
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
|
EP3458069B1
(en)
|
2016-05-18 |
2023-07-05 |
Mersana Therapeutics, Inc. |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US11110179B2
(en)
|
2016-06-03 |
2021-09-07 |
Seagen Inc. |
Combination of CD33 antibody drug conjugates with chemotherapeutic agents
|
|
WO2017214458A2
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
TWI762487B
(zh)
|
2016-06-08 |
2022-05-01 |
美商艾伯維有限公司 |
抗-b7-h3抗體及抗體藥物結合物
|
|
MX2018015274A
(es)
|
2016-06-08 |
2019-10-07 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
|
EP3468993A1
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
MX2018015285A
(es)
|
2016-06-08 |
2019-09-18 |
Abbvie Inc |
Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco.
|
|
EP3469001A4
(en)
|
2016-06-09 |
2020-05-06 |
Seattle Genetics, Inc. |
COMBINATIONS OF PBD-BASED ANTIBODY CONJUGATES WITH FLT3 INHIBITORS
|
|
US20190328901A1
(en)
|
2016-06-17 |
2019-10-31 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of cells
|
|
JP7049276B2
(ja)
|
2016-06-24 |
2022-04-06 |
メルサナ セラピューティクス インコーポレイテッド |
ピロロベンゾジアゼピンおよびその結合体
|
|
US20190218294A1
(en)
|
2016-09-09 |
2019-07-18 |
Bristol-Myers Squibb Company |
Use of an anti-pd-1 antibody in combination with an anti-mesothelin antibody in cancer treatment
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
GB201619490D0
(en)
*
|
2016-11-17 |
2017-01-04 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
US11702481B2
(en)
|
2016-12-16 |
2023-07-18 |
Bluefin Biomedicine, Inc. |
Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereof
|
|
SG11201906200WA
(en)
|
2017-01-06 |
2019-08-27 |
Avidity Biosciences Llc |
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
|
|
SG11201906319XA
(en)
|
2017-01-20 |
2019-08-27 |
Magenta Therapeutics Inc |
Compositions and methods for the depletion of cd137+ cells
|
|
US11384098B2
(en)
|
2017-02-08 |
2022-07-12 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
MX375569B
(es)
|
2017-02-08 |
2025-03-04 |
Adc Therapeutics Sa |
Conjugados de pirrolobenzodiazepinas y anticuerpos
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3589320A4
(en)
|
2017-02-28 |
2020-12-23 |
Seagen Inc. |
ANTIBODIES UNDERGOING CYSTEINE MUTATION FOR CONJUGATION
|
|
US20200061031A1
(en)
|
2017-02-28 |
2020-02-27 |
Kinki University |
Method for treating egfr-tki-resistant non-small cell lung cancer by administration of anti-her3 antibody-drug conjugate
|
|
MX2019010769A
(es)
*
|
2017-03-24 |
2019-12-11 |
Seattle Genetics Inc |
Proceso para la preparacion de enlazadores de farmacos de glucuronidos y compuestos intermediarios de los mismos.
|
|
TW201836647A
(zh)
|
2017-04-06 |
2018-10-16 |
美商艾伯維有限公司 |
抗－ｐｒｌｒ抗體藥物軛合物（ａｄｃ）及其用途
|
|
SI3612537T1
(sl)
|
2017-04-18 |
2022-10-28 |
Medimmune Limited |
Konjugati pirolobenzodiazepina
|
|
JP7408396B2
(ja)
|
2017-04-20 |
2024-01-05 |
アーデーセー セラピューティクス ソシエテ アノニム |
併用療法
|
|
JOP20190245A1
(ar)
|
2017-04-20 |
2019-10-15 |
Novartis Ag |
أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
|
|
WO2018209239A1
(en)
|
2017-05-11 |
2018-11-15 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
JP7762498B2
(ja)
|
2017-05-25 |
2025-10-30 |
ブリストル－マイヤーズ スクイブ カンパニー |
修飾重鎖定常領域を含む抗体
|
|
BR112019026564A2
(pt)
|
2017-06-14 |
2020-06-30 |
Adc Therapeutics Sa |
regimes de dosagem para a administração de um adc anti-cd19
|
|
JP7245239B2
(ja)
|
2017-06-23 |
2023-03-23 |
ベロスバイオ・インコーポレイテッド |
Ｒｏｒ１抗体免疫複合体
|
|
GB201711809D0
(en)
|
2017-07-21 |
2017-09-06 |
Governors Of The Univ Of Alberta |
Antisense oligonucleotide
|
|
WO2019023247A1
(en)
|
2017-07-25 |
2019-01-31 |
Immutics, Inc. |
TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
|
|
KR102312910B1
(ko)
|
2017-08-18 |
2021-10-15 |
메디뮨 리미티드 |
피롤로벤조디아제핀 컨쥬게이트
|
|
AU2018326877A1
(en)
*
|
2017-09-02 |
2020-03-05 |
Abbvie Inc. |
Anti-EGFR antibody drug conjugates (ADC) and uses thereof
|
|
US20200216463A1
(en)
|
2017-09-20 |
2020-07-09 |
Ph Pharma Co., Ltd. |
Thailanstatin analogs
|
|
TWI885539B
(zh)
|
2017-09-29 |
2025-06-01 |
日商第一三共股份有限公司 |
抗體－吡咯并苯二氮呯衍生物複合體
|
|
WO2019071028A1
(en)
|
2017-10-04 |
2019-04-11 |
Avidity Biosciences Llc |
NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
CA3080146A1
(en)
*
|
2017-11-13 |
2019-05-19 |
The Regents Of The University Of California |
Compositions and methods for enhancing visual function
|
|
CN111417409B
(zh)
|
2017-11-14 |
2022-07-08 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂䓬缀合物
|
|
WO2019104289A1
(en)
|
2017-11-27 |
2019-05-31 |
Mersana Therapeutics, Inc. |
Pyrrolobenzodiazepine antibody conjugates
|
|
SG11202005022YA
(en)
|
2017-12-06 |
2020-06-29 |
Avidity Biosciences Inc |
Compositions and methods of treating muscle atrophy and myotonic dystrophy
|
|
EP3724225A1
(en)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics, Inc. |
Anti-cct5 binding molecules and methods of use thereof
|
|
CN111757757A
(zh)
|
2017-12-21 |
2020-10-09 |
梅尔莎纳医疗公司 |
吡咯并苯并二氮呯抗体共轭物
|
|
GB201721802D0
(en)
|
2017-12-22 |
2018-02-07 |
Almac Discovery Ltd |
Ror1-specific antigen binding molecules
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
CN120586086A
(zh)
|
2018-03-28 |
2025-09-05 |
田边三菱制药株式会社 |
cMET单克隆结合剂的药物缀合物及其用途
|
|
GB201806022D0
(en)
*
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3829648A1
(en)
|
2018-07-27 |
2021-06-09 |
Promega Corporation |
Quinone-containing conjugates
|
|
JPWO2020059772A1
(ja)
|
2018-09-20 |
2021-08-30 |
第一三共株式会社 |
抗ｈｅｒ３抗体−薬物コンジュゲート投与によるｈｅｒ３変異がんの治療
|
|
AU2019379418A1
(en)
|
2018-11-14 |
2021-06-03 |
Daiichi Sankyo Company, Limited |
Anti-CDH6 antibody-pyrrolobenzodiazepine derivative conjugate
|
|
WO2020112781A1
(en)
|
2018-11-28 |
2020-06-04 |
Bristol-Myers Squibb Company |
Antibodies comprising modified heavy constant regions
|
|
DK3886914T3
(da)
|
2018-11-30 |
2023-07-03 |
Bristol Myers Squibb Co |
Antistof omfattende en glutaminholdig letkæde-c-terminal forlængelse, konjugater deraf og fremgangsmåder samt anvendelser
|
|
US12478686B2
(en)
|
2018-12-12 |
2025-11-25 |
Bristol-Myers Squibb Company |
Antibodies modified for transglutaminase conjugation, conjugates thereof, and methods and uses
|
|
WO2020127573A1
(en)
|
2018-12-19 |
2020-06-25 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine resistance
|
|
GB201820725D0
(en)
|
2018-12-19 |
2019-01-30 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine resistance
|
|
IL319265A
(en)
|
2018-12-21 |
2025-04-01 |
Avidity Biosciences Inc |
Anti-transferrin receptor antibodies and their uses
|
|
JP7542266B2
(ja)
*
|
2019-01-03 |
2024-08-30 |
リガケム バイオサイエンシズ， インク． |
安定性が向上したピロロベンゾジアゼピン二量体化合物及びその用途
|
|
AU2020214796A1
(en)
|
2019-01-30 |
2021-07-29 |
Truebinding, Inc. |
Anti-Gal3 antibodies and uses thereof
|
|
GB201902495D0
(en)
*
|
2019-02-25 |
2019-04-10 |
Medimmune Ltd |
Methods of synthesis and intermediates
|
|
SG11202108900WA
(en)
|
2019-03-15 |
2021-09-29 |
Medimmune Ltd |
Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
|
|
CN113631194A
(zh)
*
|
2019-03-21 |
2021-11-09 |
伊缪诺金公司 |
制备细胞结合剂-药物缀合物的方法
|
|
AU2020246448A1
(en)
|
2019-03-25 |
2021-10-14 |
Daiichi Sankyo Company, Limited |
Anti-HER2 antibody-pyrrolobenzodiazepine derivative conjugate
|
|
KR20210143237A
(ko)
|
2019-03-25 |
2021-11-26 |
다이이찌 산쿄 가부시키가이샤 |
항체-피롤로벤조디아제핀 유도체 컨쥬게이트
|
|
US20220168438A1
(en)
|
2019-03-27 |
2022-06-02 |
Daiichi Sankyo Company, Limited |
Combination of antibody-pyrrolobenzodiazepine derivative conjugate and parp inhibitor
|
|
EP3959319A4
(en)
|
2019-04-25 |
2023-06-07 |
Avidity Biosciences, Inc. |
NUCLEIC ACID COMPOSITIONS AND METHODS FOR MULTI-EXON SKIPPING
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
CN114375297A
(zh)
|
2019-06-06 |
2022-04-19 |
艾维迪提生物科学公司 |
Una亚酰胺及其用途
|
|
WO2020247782A1
(en)
|
2019-06-06 |
2020-12-10 |
Avidity Biosciences, Inc. |
Nucleic acid-polypeptide compositions and uses thereof
|
|
GB201908128D0
(en)
|
2019-06-07 |
2019-07-24 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP7515567B2
(ja)
|
2019-08-06 |
2024-07-12 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
生物医薬組成物及び関連する方法
|
|
CN113330029A
(zh)
*
|
2019-08-19 |
2021-08-31 |
沈阳药科大学 |
抗体的突变体及其应用
|
|
US20240377413A1
(en)
|
2019-09-16 |
2024-11-14 |
Bristol-Myers Squibb Company |
Dual capture method for analysis of antibody-drug conjugates
|
|
US20240123081A1
(en)
|
2019-10-25 |
2024-04-18 |
Medimmune, Llc |
Branched moiety for use in conjugates
|
|
JP7788060B2
(ja)
|
2020-03-19 |
2025-12-18 |
アビディティー バイオサイエンシーズ，インク． |
顔面肩甲上腕型筋ジストロフィーを処置するための組成物および方法
|
|
JP7748962B2
(ja)
|
2020-03-27 |
2025-10-03 |
アビディティー バイオサイエンシーズ，インク． |
筋ジストロフィーを処置するための組成物および方法
|
|
CA3177843A1
(en)
|
2020-05-13 |
2021-11-18 |
John Thomas MULLIGAN |
Compositions of protein complexes and methods of use thereof
|
|
US12281166B2
(en)
|
2020-05-26 |
2025-04-22 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking Galectin-3
|
|
TW202216212A
(zh)
|
2020-07-17 |
2022-05-01 |
日商第一三共股份有限公司 |
抗體-藥物結合物之製造方法
|
|
WO2022050300A1
(ja)
|
2020-09-02 |
2022-03-10 |
第一三共株式会社 |
新規エンド－β－Ｎ－アセチルグルコサミニダーゼ
|
|
EP4277664A1
(en)
|
2021-01-13 |
2023-11-22 |
Memorial Sloan Kettering Cancer Center |
Antibody-pyrrolobenzodiazepine derivative conjugate
|
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
WO2022182415A1
(en)
|
2021-02-24 |
2022-09-01 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
EP4370555A4
(en)
|
2021-07-13 |
2025-11-12 |
Truebinding Inc |
METHODS FOR PREVENTING PROTEIN AGGREGATION
|
|
EP4380981A2
(en)
|
2021-08-03 |
2024-06-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Biopharmaceutical compositions and stable isotope labeling peptide mapping method
|
|
US11912779B2
(en)
|
2021-09-16 |
2024-02-27 |
Avidity Biosciences, Inc. |
Compositions and methods of treating facioscapulohumeral muscular dystrophy
|
|
US20230279120A1
(en)
|
2021-11-09 |
2023-09-07 |
Truebinding, Inc. |
Methods of treating or inhibiting cardiovascular diseases
|
|
US20250034274A1
(en)
|
2021-11-30 |
2025-01-30 |
Daiichi Sankyo Company , Limited |
Protease-cleavable masked antibodies
|
|
KR20240125036A
(ko)
|
2021-12-23 |
2024-08-19 |
마이레큘, 인크. |
폴리뉴클레오타이드의 전달을 위한 조성물
|
|
TW202342106A
(zh)
|
2022-02-09 |
2023-11-01 |
日商第一三共股份有限公司 |
環境應答性遮蔽抗體及其利用
|
|
CA3253428A1
(en)
|
2022-03-02 |
2025-06-16 |
Daiichi Sankyo Company, Limited |
PROCESS FOR PRODUCING A MOLECULE CONTAINING Fc
|
|
US12071621B2
(en)
|
2022-04-05 |
2024-08-27 |
Avidity Biosciences, Inc. |
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
|
|
CA3247696A1
(en)
|
2022-04-07 |
2025-02-03 |
Twinpig Biolab Inc. |
NEW ANTICANCER IMMUNOTHERAPEUTIC AGENT BASED ON PEPTIDE
|
|
CN119486758A
(zh)
|
2022-06-30 |
2025-02-18 |
东丽株式会社 |
癌的治疗和/或预防用药物组合物
|
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
|
WO2024107765A2
(en)
|
2022-11-14 |
2024-05-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
|
CN121219016A
(zh)
|
2023-06-02 |
2025-12-26 |
第一三共株式会社 |
抗-her3抗体-药物缀合物和rasg12c抑制剂的组合
|
|
US12491257B2
(en)
|
2023-06-27 |
2025-12-09 |
Avidity Biosciences, Inc. |
Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conjugates
|
|
WO2025007063A1
(en)
|
2023-06-30 |
2025-01-02 |
Avidity Biosciences, Inc. |
Compositions and methods of using pln-targeting antibody-oligonucleotide conjugates
|
|
WO2025096716A1
(en)
|
2023-11-01 |
2025-05-08 |
Incyte Corporation |
Anti-mutant calreticulin (calr) antibody-drug conjugates and uses thereof
|